Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Heart Failure

Free Subscription 15.09.2025 1 Am Heart J 2 Am J Cardiol 1 Basic Res Cardiol 1 Circ Heart Fail 2 Clin Cardiol 4 Eur Heart J 14 Eur J Heart Fail 3 Int J Cardiol 2 J Am Coll Cardiol 2 J Card Fail 2 J Cardiol 1 J Cardiovasc Pharmacol 1 J Thorac Cardiovasc Surg 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. GOLDENBERG I, Zareba W, Ezekowitz JA, Albert C, et al
   Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trial.
   Am Heart J. 2025 Sep 4:S0002-8703(25)00320-5. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. VACEK JL
   Climbing to the Summit of Guideline Directed Therapy of Heart Failure: A Slippery Slope.
   Am J Cardiol. 2025 Sep 6:S0002-9149(25)00540.
   PubMed        
   
   
3. TIAN F, Hu C, Liu W, Zhang B, et al
   Noninvasive Right Ventricular Myocardial Work by Pressure-Strain Loop: A New Perspective on Right Ventricular Function and Cardiac Resynchronization Therapy.
   Am J Cardiol. 2025;252:8-15.
   PubMed         Abstract available
   
   

   
   Basic Res Cardiol

4. LI Z, Freiberg S, Music ML, Gu L, et al
   Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy.
   Basic Res Cardiol. 2025 Sep 11. doi: 10.1007/s00395-025-01136.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

5. REDDY YNV, Frantz RP, Hassoun PM, Hemnes A, et al
   Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension.
   Circ Heart Fail. 2025 May 29:e012912. doi: 10.1161/CIRCHEARTFAILURE.125.012912.
   PubMed         Abstract available
   
   

   
   Clin Cardiol

6. TAHIR I, Shahbaz H, Khattak A
   "Bridging Guidelines and Real World Barriers: Reflections on GDMT Optimization in Heart Failure".
   Clin Cardiol. 2025;48:e70206.
   PubMed        
   
   
7. HIMRAL S, Sharma J, Sandal S, Mahajan K, et al
   SGLT2 Inhibitors and Sleep Quality in Heart Failure: Implications for Patient-Centered Outcomes.
   Clin Cardiol. 2025;48:e70208.
   PubMed        
   
   

   
   Eur Heart J

8. CREA F
   Myocarditis after COVID-19, sepsis-induced cardiomyopathy, and haemodynamic assessment of heart failure: focus on the myocardium.
   Eur Heart J. 2025;46:3315-3318.
   PubMed        
   
   
9. MENTE A, Miller V, Yusuf S
   Diet and heart failure: evidence is limited to make recommendations.
   Eur Heart J. 2025 Sep 9:ehaf521. doi: 10.1093.
   PubMed        
   
   
10. NEUEN BL, Vaduganathan M
    Glomerular filtration rate slope in heart failure: ready for prime time?
    Eur Heart J. 2025 Sep 9:ehaf643. doi: 10.1093.
    PubMed        
    
    
11. GOTTHARDT M
    RNA-binding proteins as therapeutic targets in cardiac fibrosis and heart failure.
    Eur Heart J. 2025 Sep 9:ehaf644. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Heart Fail

12. NASSIRI S, Voordes GHD, Handoko ML, Voors AA, et al
    Reply to the letter regarding the article 'Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70038.
    PubMed        
    
    
13. BARAKAT MF, Amaral N, Brayson D, Amin-Youssef G, et al
    Ferric derisomaltose augments intrinsic skeletal muscle electron transport chain activity in heart failure: A FERRIC-HF II molecular substudy.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70028.
    PubMed         Abstract available
    
    
14. OSTROMINSKI JW, Claggett BL, Desai AS, Jhund PS, et al
    Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trial.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70034.
    PubMed         Abstract available
    
    
15. ALMESNED MA, van Essen BJ, Voors AA, Lipsic E, et al
    Reply to the letter regarding the article 'Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70044.
    PubMed        
    
    
16. CHANG HC, Gau SY
    Letter regarding the article 'Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70045.
    PubMed        
    
    
17. IVANOVSKI M, Mrak M, Meznar AZ, Jan M, et al
    The CONDUCT-AF trial: Rationale and design of a prospective, randomized, multicentre study comparing conduction system and biventricular pacing in patients undergoing atrioventricular node ablation for heart failure with atrial fibrillation.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70013.
    PubMed         Abstract available
    
    
18. CAMPAIN J, Wakeham DJ, Dias K, MacNamara JP, et al
    Distinct blood volume and left ventricular adaptation to severe obesity in middle-aged adults at risk for heart failure.
    Eur J Heart Fail. 2025 Sep 9. doi: 10.1002/ejhf.70037.
    PubMed         Abstract available
    
    
19. SHAH P, Bekfani T, Rubis P, Clark AL, et al
    Potential therapeutic effects of warming on patients with heart failure.
    Eur J Heart Fail. 2025 Sep 9. doi: 10.1002/ejhf.70011.
    PubMed        
    
    
20. BEER BN, Benson L, Basile C, Schrage B, et al
    Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes.
    Eur J Heart Fail. 2025 Sep 11. doi: 10.1002/ejhf.70046.
    PubMed         Abstract available
    
    
21. KERAMIDA K, Lopez-Fernandez T, Anker MS, Petrie MC, et al
    Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology.
    Eur J Heart Fail. 2025 Sep 12. doi: 10.1002/ejhf.70005.
    PubMed         Abstract available
    
    
22. YANG Z, Kou L, Liao S
    Letter regarding the article 'Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70039.
    PubMed        
    
    
23. ECHEVERRIA LE, Bocchi E, Demacq C, de Barros E Silva PGM, et al
    Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70026.
    PubMed         Abstract available
    
    
24. KEMPF T, Fuge J, Bauersachs J
    Reply to the letter regarding the article 'Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70029.
    PubMed        
    
    
25. SUN P
    Letter regarding the article 'Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70024.
    PubMed        
    
    

    
    Int J Cardiol

26. RANA AM, Rafay MA, Amjad MW, Aslam MH, et al
    Critical appraisal of early diagnosis and progression to heart failure with preserved ejection fraction among hypertensive patients with left ventricular hypertrophy.
    Int J Cardiol. 2025 Sep 6:133877. doi: 10.1016/j.ijcard.2025.133877.
    PubMed        
    
    
27. UMAR M, Zaheer M, Gillani Z
    Letter to the Editor: Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.
    Int J Cardiol. 2025 Sep 6:133871. doi: 10.1016/j.ijcard.2025.133871.
    PubMed        
    
    
28. CHEN X, Zhang Q, Bao Y
    Reconsidering thyroid hormone assessment in heart failure risk prediction.
    Int J Cardiol. 2025 Sep 8:133872. doi: 10.1016/j.ijcard.2025.133872.
    PubMed        
    
    

    
    J Am Coll Cardiol

29. RICCARDI M, Pagnesi M, Lombardi CM, Anker SD, et al
    Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies.
    J Am Coll Cardiol. 2025;86:813-828.
    PubMed         Abstract available
    
    
30. BLUMER V, Lindenfeld J, Lala A, Carson P, et al
    Let Us Call It Cardiogenic Preshock: A Working Definition From the Heart Failure Collaboratory.
    J Am Coll Cardiol. 2025;86:832-835.
    PubMed        
    
    

    
    J Card Fail

31. LALA A, Mentz RJ
    The Value of Community in Heart Failure.
    J Card Fail. 2025;31:1377-1378.
    PubMed        
    
    
32. 
    Celebrate 30 Years of HFSA at ASM 2025 - Reunite, Reflect, and Reimagine the Future of Heart Failure.
    J Card Fail. 2025;31:1493-1495.
    PubMed        
    
    

    
    J Cardiol

33. MORI Y, Natori S, Arai T, Kakuya F, et al
    Biomarker-based pre-heart failure screening in a middle-aged rural population.
    J Cardiol. 2025 Sep 4:S0914-5087(25)00223-0. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    
34. PENG JR, Chen TH, Chen DY, Lin Y, et al
    SGLT2i with ARNi versus RASi in Heart Failure with Reduced Ejection Fraction: Improved Survival and Reduced Hyperkalemia Risk in a Real-World Cohort Study.
    J Cardiol. 2025 Sep 10:S0914-5087(25)00225-4. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

35. HOGWOOD AC, Golino M, Moroni F, Canada JM, et al
    The Effects of Anakinra on Cardiorespiratory Fitness in Heart Failure Stratified by Age in Phase II Clinical Trials.
    J Cardiovasc Pharmacol. 2025 Sep 9. doi: 10.1097/FJC.0000000000001756.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

36. DAVIES RR, Iqbal M, Lantz-Thomason J, Carrington S, et al
    Paracorporeal continuous flow ventricular assist devices (cfvads) for children < 20 kg: Challenging the paradigm in the smallest patients.
    J Thorac Cardiovasc Surg. 2025 Apr 29:S0022-5223(25)00323.
    PubMed         Abstract available
    
    

    
    PLoS One

37. TAHA K, Ross HJ, Peikari M, Mueller B, et al
    Predicting the future risk and outcomes of severe heart failure and coronary artery disease with machine learning in the UK Biobank Cohort.
    PLoS One. 2025;20:e0329461.
    PubMed         Abstract available
    
    
38. DAI L, Hu J, Yang Y, Qian B, et al
    1p-Enh-regulated CYP4B1 alleviates NNK-induced heart failure and lung cancer via the STAT3 pathway.
    PLoS One. 2025;20:e0331471.
    PubMed         Abstract available
    
    
39. NENDL A, Raju SC, Braadland PR, Nordborg A, et al
    Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosis.
    PLoS One. 2025;20:e0331692.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.